DCGI approves SEC's emergency use recommendation for Sputnik V vaccine
• 4 years agoSputnik V, backed by the RDIF, already has production agreements in India to produce 852 million doses.
Russia's Sputnik V COVID-19 vaccine gets expert panel nod for emergency use in India
Tech2 News Staff • 4 years agoDr Reddy's conducted the bridge trials in India and will distribute some 100 million doses of the vaccine in India.
Russia approves its first Coronavirus vaccine before even completing its clinical trials
• 5 years agoThe Gamaleya Institute developed the Russian vaccine using a human cell line first cultured in 1973 — the same line used in the Oxford-AstraZeneca vaccine.